GenSight Biologics S.A.
GSGTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,967 | -$8,153 | -$5,848 | -$14,258 |
| Dep. & Amort. | $172 | -$371 | $1,430 | $1,521 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $237 | $389 | $395 | $422 |
| Change in WC | $4,940 | $786 | $87 | $6,368 |
| Other Non-Cash | -$1,536 | $1,757 | -$3,409 | -$2,508 |
| Operating Cash Flow | -$3,153 | -$5,592 | -$7,345 | -$8,455 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$1 | -$10 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$62 | $5 | $13 | $66 |
| Investing Cash Flow | -$62 | $5 | $12 | $56 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$354 | -$2,153 | -$407 | $0 |
| Stock Issued | $1,041 | $16,742 | $0 | $0 |
| Stock Repurch. | $0 | -$5 | -$22 | -$99 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$64 | -$13,177 | $12,564 | $9,550 |
| Financing Cash Flow | $623 | $1,407 | $12,135 | $9,451 |
| Forex Effect | $360 | -$297 | $4 | $62 |
| Net Chg. in Cash | -$2,233 | -$4,476 | $6,940 | $557 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,551 | $6,940 | $2,100 | $1,021 |
| End Cash | $318 | $2,464 | $6,940 | $557 |
| Free Cash Flow | -$3,153 | -$5,592 | -$7,346 | -$8,465 |